
How Cannabis Reclassification Could Impact Workplaces
A potential shift in federal marijuana policy could bring important changes for employers across the United States. Federal officials have been directed to explore reclassifying marijuana from a Schedule I drug to Schedule III under the Controlled Substances Act.
If that change occurs, cannabis would move into the same category as certain prescription medications, including some painkillers that contain codeine. This adjustment could open the door for cannabis to be prescribed for recognized medical purposes and may influence how employers approach workplace policies, drug testing, and employee accommodations.
While the change would not automatically legalize marijuana use in the workplace, it could lead employers to review their policies and procedures to ensure they remain compliant and practical.
Understanding What Reclassification Means
Currently, marijuana is classified as a Schedule I drug at the federal level, meaning it is considered to have no accepted medical use under federal law. Moving it to Schedule III would acknowledge legitimate medical applications and allow physicians to prescribe cannabis-based treatments in certain circumstances.
For employers, this shift could create new considerations around medical use, workplace accommodations, and how drug policies are applied.
Medical Accommodation and the ADA
If cannabis becomes a Schedule III medication, some employees may receive prescriptions for cannabis-related treatments. In those situations, employers may need to consider requests for reasonable accommodations under the Americans with Disabilities Act (ADA).
Possible accommodation requests could include:
- Off-duty use of prescribed cannabis products
- Use of non-intoxicating cannabis-derived products such as cannabidiol (CBD)
- Adjustments that allow employees to manage medical symptoms while meeting job responsibilities
However, employers would not be required to allow cannabis use that creates safety risks or prevents employees from performing essential job duties. Workplace intoxication or unsafe behavior would still be prohibited.
Drug Testing Policies May Evolve
Many employers already limit or eliminate marijuana testing during pre-employment screening, particularly in states with restrictions on cannabis testing. Federal reclassification could further broaden this trend, especially for roles that are not safety-sensitive.
Even with possible policy changes, employers would still have the ability to:
- Prohibit employees from being impaired at work
- Conduct testing when there is reasonable suspicion of impairment
- Maintain zero-tolerance policies where allowed by state law
The broader shift may move workplace policies toward impairment-based enforcement rather than blanket drug testing.
Implications for Transportation and Safety-Sensitive Jobs
Industries regulated by the Department of Transportation (DOT), including trucking, aviation, rail, and transit, may face additional regulatory questions.
Some legal experts suggest that if marijuana is removed from Schedule I, the existing federal authority that supports mandatory marijuana testing for safety-sensitive transportation workers could be affected. New legislation or regulations might be needed to maintain those testing requirements.
However, these changes would not happen immediately. For now, employers regulated by the DOT must continue following current drug testing rules.
Preparing for Questions from Employees
If marijuana is reclassified, some employees may assume that cannabis use is now broadly allowed. Employers should be prepared to explain that reclassification does not eliminate workplace policies or safety expectations.
Employers may want to consider the following steps:
- Review and update drug and alcohol policies
- Clarify expectations regarding impairment during work hours
- Train supervisors to recognize signs of impairment
- Monitor federal and state regulatory developments
- Prepare to address employee questions about medical cannabis use
What Employers Should Expect
Reclassifying marijuana would not instantly change workplace norms. However, it would cause employers to adopt more nuanced policies that focus on workplace impairment and safety rather than simple drug presence.
For many organizations, the most effective approach will involve balancing employee health needs with operational safety and compliance requirements.
As cannabis policy continues to evolve, employers should stay informed and work with legal and benefits professionals to ensure their workplace policies remain clear, compliant, and practical.
Browse Recent Posts










